Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them

US Patent 6710042 · Granted Mar 23, 2004

Estimated economic value: $2,102,000

Assignee

Inventors

View full patent text on Google Patents →